Journal details
DRUG DESIGN DEVELOPMENT AND THERAPY
DOVE MEDICAL PRESS LTD · ISSN 1177-8881 · eISSN 1177-8881
SCIEScopusMEDLINEPubMedPMCDOAJ
Overview
DRUG DESIGN DEVELOPMENT AND THERAPY. ISSN 1177-8881 · eISSN 1177-8881. published by DOVE MEDICAL PRESS LTD. England. Chemistry, Medicinal · Pharmacology & Pharmacy. impact factor 6.1 (2025). JCR Q1. CAS Zone 2. indexed in SCIE, Scopus, MEDLINE, PubMed, PMC, DOAJ. Figures below are the public fields already in this dataset. Confirm scope, APC and policies on the journal website before you submit.
Publication output
2026: 398 articles · 2025: 763 articles · 2024: 427 articles. Source: OpenAlex open data.
FAQ
What is the impact factor of DRUG DESIGN DEVELOPMENT AND THERAPY?
The impact factor recorded for DRUG DESIGN DEVELOPMENT AND THERAPY is 6.1 (2025 JCR release), JCR quartile Q1.
What is the CAS zone (Chinese Academy of Sciences ranking) of DRUG DESIGN DEVELOPMENT AND THERAPY?
DRUG DESIGN DEVELOPMENT AND THERAPY is listed in CAS Zone 2.
Which databases index DRUG DESIGN DEVELOPMENT AND THERAPY?
DRUG DESIGN DEVELOPMENT AND THERAPY is indexed in SCIE, Scopus, MEDLINE, PubMed, PMC, DOAJ. Confirm on the journal website and the database itself before submitting.